We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – Commentary.
- Authors
Corboy, John R.
- Abstract
The article discusses a study related to emergence of safe treatments and disease-modifying therapy (DMT) for multiple sclerosis (MS). It mentions that the apparent reduction in efficacy of the available DMTs in the aging MS patient should focus towards meningeal infiltrates, cortical abnormalities and microglial activation that is seen in progressive MS. It also mentions that discontinuation of medications like natalizumab may be associated with enhanced risk of recurrence.
- Subjects
MULTIPLE sclerosis; MULTIPLE sclerosis treatment; MULTIPLE sclerosis research; DRUG efficacy; NATALIZUMAB; DISEASE relapse; PATIENTS; THERAPEUTICS
- Publication
Multiple Sclerosis Journal, 2017, Vol 23, Issue 9, p1192
- ISSN
1352-4585
- Publication type
Article
- DOI
10.1177/1352458517717809